208 related articles for article (PubMed ID: 32848452)
1. Long-Noncoding RNA FGD5-AS1 Enhances the Viability, Migration, and Invasion of Glioblastoma Cells by Regulating the miR-103a-3p/TPD52 Axis.
Su D; Ji Z; Xue P; Guo S; Jia Q; Sun H
Cancer Manag Res; 2020; 12():6317-6329. PubMed ID: 32848452
[TBL] [Abstract][Full Text] [Related]
2. FGD5-AS1 Inhibits Osteoarthritis Development by Modulating miR-302d-3p/TGFBR2 Axis.
Yang Y; Sun Z; Liu F; Bai Y; Wu F
Cartilage; 2021 Dec; 13(2_suppl):1412S-1420S. PubMed ID: 33834880
[TBL] [Abstract][Full Text] [Related]
3. LncRNA FGD5-AS1 promotes tumor growth by regulating MCL1 via sponging miR-153-3p in oral cancer.
Ge C; Dong J; Chu Y; Cao S; Zhang J; Wei J
Aging (Albany NY); 2020 Jul; 12(14):14355-14364. PubMed ID: 32675387
[TBL] [Abstract][Full Text] [Related]
4. FGD5-AS1 facilitates glioblastoma progression by activation of Wnt/β-catenin signaling via regulating miR-129-5p/HNRNPK axis.
Wu L; Zhu X; Song Z; Guo M; Liang J; Yan D
Life Sci; 2020 Sep; 256():117998. PubMed ID: 32585241
[TBL] [Abstract][Full Text] [Related]
5. Long Noncoding RNA FGD5-AS1 Knockdown Decrease Viability, Migration, and Invasion of Non-Small Cell Lung Cancer (NSCLC) Cells by Regulating the MicroRNA-944/MACC1 Axis.
Lv J; Li Q; Ma R; Wang Z; Yu Y; Liu H; Miao Y; Jiang S
Technol Cancer Res Treat; 2021; 20():1533033821990090. PubMed ID: 33550920
[TBL] [Abstract][Full Text] [Related]
6. miR-103a-3p Suppresses Cell Proliferation and Invasion by Targeting Tumor Protein D52 in Prostate Cancer.
Ge J; Mao L; Xu W; Fang W; Wang N; Ye D; Dong Z; Guan H; Guan C
J Invest Surg; 2021 Sep; 34(9):984-992. PubMed ID: 32166986
[TBL] [Abstract][Full Text] [Related]
7. LncRNA FGD5-AS1/miR-5590-3p axis facilitates the proliferation and metastasis of renal cell carcinoma through ERK/AKT signalling.
Yang Y; Dong MH; Hu HM; Min QH; Xiao L
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8756-8766. PubMed ID: 32964964
[TBL] [Abstract][Full Text] [Related]
8. FXR1 promotes glioma progression by downregulating microRNA-124-3p through long noncoding RNA FGD5-AS1 upregulation.
Gong X; Huang M; Chen L; Zeng H
Acta Neurol Belg; 2023 Aug; 123(4):1453-1464. PubMed ID: 37074635
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA FGD5-AS1 enhances osteosarcoma cell proliferation and migration by targeting miR-506-3p/RAB3D axis.
Li C; Lin X; Zhang C; Wan L; Yin J; Wang B
Hum Cell; 2021 Jul; 34(4):1255-1265. PubMed ID: 33891267
[TBL] [Abstract][Full Text] [Related]
10. Thalidomide suppresses angiogenesis and immune evasion via lncRNA FGD5-AS1/miR-454-3p/ZEB1 axis-mediated VEGFA expression and PD-1/PD-L1 checkpoint in NSCLC.
Xia Y; Wang WC; Shen WH; Xu K; Hu YY; Han GH; Liu YB
Chem Biol Interact; 2021 Nov; 349():109652. PubMed ID: 34520751
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA FGD5-AS1 contributes to cisplatin resistance in hepatocellular carcinoma via sponging microRNA-153-3p by upregulating Twinfilin Actin Binding Protein 1 (TWF1).
Yang Y; Shi L; Zhang D; Wu D; An Y; Zhang Y; Chen X
Bioengineered; 2021 Dec; 12(1):6713-6723. PubMed ID: 34519634
[TBL] [Abstract][Full Text] [Related]
12. Silencing of Long Non-Coding RNA FGD5-AS1 Inhibits the Progression of Non-Small Cell Lung Cancer by Regulating the miR-493-5p/DDX5 Axis.
Cui F; Luo P; Bai Y; Meng J
Technol Cancer Res Treat; 2021; 20():1533033821990007. PubMed ID: 33550957
[TBL] [Abstract][Full Text] [Related]
13. Long Non-coding RNA FGD5-AS1 Regulates Cancer Cell Proliferation and Chemoresistance in Gastric Cancer Through miR-153-3p/CITED2 Axis.
Gao Y; Xie M; Guo Y; Yang Q; Hu S; Li Z
Front Genet; 2020; 11():715. PubMed ID: 32849774
[TBL] [Abstract][Full Text] [Related]
14. FGD5-AS1 facilitates the osteogenic differentiation of human bone marrow-derived mesenchymal stem cells via targeting the miR-506-3p/BMP7 axis.
Li J; Wu X; Shi Y; Zhao H
J Orthop Surg Res; 2021 Nov; 16(1):665. PubMed ID: 34772438
[TBL] [Abstract][Full Text] [Related]
15. LncRNA FGD5-AS1 Alleviates Inflammation in Allergic Rhinitis through the miR-223-3p/COX11 Axis.
Li B; Yu X; Pang F
Int Arch Allergy Immunol; 2024; 185(3):201-211. PubMed ID: 38071964
[TBL] [Abstract][Full Text] [Related]
16. LncRNA FGD5-AS1 accelerates cell proliferation in pancreatic cancer by regulating miR-520a-3p/KIAA1522 axis.
Lin J; Liao S; Liu Z; Li E; Wu X; Zeng W
Cancer Biol Ther; 2021 Mar; 22(3):257-266. PubMed ID: 33794727
[TBL] [Abstract][Full Text] [Related]
17. LncRNA FGD5-AS1 promotes the malignant phenotypes of ovarian cancer cells via targeting miR-142-5p.
Aichen Z; Kun W; Xiaochun S; Lingling T
Apoptosis; 2021 Jun; 26(5-6):348-360. PubMed ID: 33974163
[TBL] [Abstract][Full Text] [Related]
18. The knockdown of LncRNA AFAP1-AS1 suppressed cell proliferation, migration, and invasion, and promoted apoptosis by regulating miR-545-3p/hepatoma-derived growth factor axis in lung cancer.
Sun J; Min H; Yu L; Yu G; Shi Y; Sun J
Anticancer Drugs; 2021 Jan; 32(1):11-21. PubMed ID: 33290312
[TBL] [Abstract][Full Text] [Related]
19. Targeting EGFR sensitizes 5-Fu-resistant colon cancer cells through modification of the lncRNA-FGD5-AS1-miR-330-3p-Hexokinase 2 axis.
Gao SJ; Ren SN; Liu YT; Yan HW; Chen XB
Mol Ther Oncolytics; 2021 Dec; 23():14-25. PubMed ID: 34589581
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA FGD5-AS1 promotes colorectal cancer cell proliferation, migration, and invasion through upregulating CDCA7 via sponging miR-302e.
Li D; Jiang X; Zhang X; Cao G; Wang D; Chen Z
In Vitro Cell Dev Biol Anim; 2019 Sep; 55(8):577-585. PubMed ID: 31332696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
